BDH Industries Ltd.
Snapshot View

View in App

Prices View details >>

144.50 +1.50 ▲1.1%

03 February 2023, 04:01:00 PM
Volume: 7,433

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.bdhind.com
Market Cap 82.13 Cr.
Enterprise Value(EV) 57.84 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 14.78 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 9.65 Trailing Twelve Months Ending 2022-09
Industry PE 32.22 Trailing Twelve Months Ending 2022-09
Book Value / Share 86.21 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.65 Calculated using Price: 142.65
Dividend Yield 2.52 Period Ending 2022-03
No. of Shares Subscribed 0.58 Cr. 5,757,300 Shares
FaceValue 10
Company Profile
BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+1.05%
1 Week
-2.27%
1 Month
-5.21%
3 Month
+3.96%
6 Month
+18.69%
1 Year
+0.80%
2 Year
+46.11%
5 Year
+91.39%
10 Year
+718.70%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 11.02 11.69 13.40 12.51 13.13 15.46 17.11 16.26 16.27
Return on Capital Employed (%) 13.55 13.25 15.39 14.90 14.74 16.94 19.14 18.74 19.61
Return on Assets (%) 5.11 5.15 6.23 6.27 6.77 7.88 9.08 9.35 10.33

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 23 24 27 29 31 34 38 43 49 51
Non Curr. Liab. 1 1 1 2 2 1 1 1 1 1
Curr. Liab. 24 27 24 23 24 30 26 27 20 20
Minority Int.
Equity & Liab. 48 52 52 54 57 66 65 71 69 71
Non Curr. Assets 15 13 17 23 23 22 21 20 20 20
Curr. Assets 33 38 35 31 34 44 44 51 49 51
Misc. Exp. not W/O
Total Assets 48 52 52 54 57 66 65 71 69 71

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 43 45 46 44 41 52 59 57 69 78
Other Income 1 1 2 1 1 1 1 1 1 1
Total Income 44 46 48 45 42 53 60 59 70 79
Total Expenditure -39 -41 -42 -39 -36 -45 -51 -49 -60 -67
PBIDT 5 5 6 6 6 8 10 10 10 11
Interest -1 0 0 0 0 -1 -1 0 0 0
Depreciation -1 -1 -1 -1 -1 -1 -1 -1 -1 -1
Taxation -1 -1 -2 -2 -1 -2 -2 -2 -2 -3
Exceptional Items 0 0
PAT 2 3 3 3 4 5 6 6 7 9
Adjusted EPS 4 4 6 6 7 8 10 11 13 15

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 5 4 6 4 7 0 -4 11 1 3
Cash Fr. Inv. -1 0 0 -5 -5 0 1 1 1 1
Cash Fr. Finan. 1 3 -3 -1 -3 -3 3 -6 -2 -8
Net Change 6 6 3 -1 -1 -2 0 6 0 -4
Cash & Cash Eqvt 12 18 21 20 19 17 17 23 23 19

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 49.79 49.79 49.73 49.66 49.66 49.66 49.66 49.66 49.66
Public 50.21 50.21 50.27 50.34 50.34 50.34 50.34 50.34 50.34
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 01 Feb 2023
Board Meeting Intimation for Considering The Standalone Unaudited Financial Results For The Third Quarter And Nine Months Ended On 31St December 2022 Of The Financial Year 2022-2023.
BDH INDUSTRIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve the Standalone Unaudited Financial Results for the third quarter and nine months ended on 31st December 2022 of the financial year 2022-2023.
Wed, 11 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
This is to certify that the details of the securities dematerialised during the quarter ended 31st December 2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished to BSE where the equity shares of the Company are listed.
Sat, 31 Dec 2022
Closure of Trading Window
This is to inform you that pursuant to Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 as amended from time to time the trading window for dealing in the securities of the Company remains closed for designated persons from 1st January 2023 till 48 hours after declaration of the unaudited financial results of the Company for the third quarter and nine months ended on 31st December 2022 of the financial year 2022-2023. The date of Board of Directors meeting for considering the unaudited financial results of the Company for the third quarter and nine months ended on 31st December 2022 of the financial year 2022-2023 shall be informed in due course of time.

Technical Scans View Details >>

Fri, 03 Feb 2023
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 246,567.66 1,027.65 +2.0%
Cipla Ltd. 82,812.97 1,026.00 +0.1%
Divi's Laboratories Ltd. 76,573.08 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. 72,577.66 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. 61,039.46 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. 52,289.82 1,545.00 +0.3%
Abbott India Ltd. 44,198.55 20,800.00 +1.5%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 58.54 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 31.39 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 25.59 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.92 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.70 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.92 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 50.12 20,800.00 +1.5%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-12 4.46 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-12 3.65 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 6.31 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.30 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.20 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.20 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-09 16.28 20,800.00 +1.5%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 0.00 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 29.95 20,800.00 +1.5%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,800.00 +1.5%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,027.65 +2.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,026.00 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 2,884.45 -11.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,358.40 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,245.20 +0.3%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,545.00 +0.3%
Abbott India Ltd. Standalone 2022-03 798.70 20,800.00 +1.5%

FAQ's On BDH Industries Ltd.

What is BDH Inds share price?
Can I buy BDH Inds shares now?
What is the Dividend Yield of BDH Inds?
What is the Market Cap of BDH Inds?
What are the key metrics to analyse BDH Inds?
What is the 52 Week High and Low of BDH Inds?
What is the trend of BDH Inds share price?